Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.62 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | DGKA | P23743 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL813361 | 0.93 | ADRA2A (0.54) | TSHRADRA2AADRA1AKMT2AMAPT | |
| SCHEMBL25492396 | 0.93 | TSHR (0.72) | TSHRADRA2AADRA1AKMT2AMAPT | |
| SCHEMBL14500172 | 0.86 | TSHR (0.56) | TSHRADRA2AADRA1AKMT2AMAPT | |
| SCHEMBL22510580 | 0.86 | ADRA2A (0.48) | TSHRADRA2AADRA1AMAPTBLM | |
| SCHEMBL13268865 | 0.86 | ADRA2A (0.48) | TSHRADRA2AADRA1AMAPTBLM | |
| SCHEMBL2302053 | 0.86 | ADRA2A (0.48) | TSHRADRA2AADRA1AMAPTBLM | |
| SCHEMBL407967 | 0.84 | ALDH1A1 (0.50) | TSHRADRA2AADRA1AMAPTBLM | |
| SCHEMBL756978 | 0.84 | ADRA2A (0.46) | TSHRADRA2AADRA1AMAPTBLM | |
| SCHEMBL813905 | 0.83 | DGKA (0.58) | TSHRADRA2AADRA1AMAPTBLM | |
| SCHEMBL1033327 | 0.83 | DGKA (0.64) | TSHRADRA2AADRA1AMAPTBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230280500-A1 | PHOTOCHROMIC COMPOUND, PHOTOCHROMIC CURABLE COMPOSITION, CURED BODY, LENS AND EYEGLASSES | TOKUYAMA CORPORATION (JP) | 2023-09-07 | — | — | US | disclosed |
| US-20230242808-A1 | PHOTOCHROMIC COMPOUND AND CURABLE COMPOSITION CONTAINING THE PHOTOCHROMIC COMPOUND | TOKUYAMA CORPORATION (JP) | 2023-08-03 | — | — | US | disclosed |
| US-20230242809-A1 | PHOTOCHROMIC HYDROXYURETHANE COMPOUND | TOKUYAMA CORPORATION (JP) | 2023-08-03 | — | — | US | disclosed |
| US-20230133211-A1 | PHOTOCHROMIC CYCLIC COMPOUND AND CURABLE COMPOSITION CONTAINING THE PHOTOCHROMIC CYCLIC COMPOUND | TOKUYAMA CORPORATION (JP) | 2023-05-04 | — | — | US | disclosed |
| EP-4047030-A1 | PHOTOCHROMIC HYDROXYURETHANE COMPOUND | Tokuyama Corporation (JP) | 2022-08-24 | — | — | EP | disclosed |
| US-9954251-B2 | Electrolyte formulations for electrochemical cells containing a silicon electrode | WILDCAT DISCOVERY TECHNOLOGIES, INC (US) | 2018-04-24 | — | — | US | disclosed |
| US-20160240889-A1 | Electrolyte Formulations For Electrochemical Cells Containing A Silicon Electrode | HSBC VENTURES USA INC. | 2016-08-18 | — | — | US | disclosed |
| US-20110190455-A1 | POLYDIALKYLSILOXANE-BRIDGED BI-PHOTOCHROMIC MOLECULES | Vivimed Labs Europe Ltd. (GB) | 2011-08-04 | — | — | US | disclosed |
| US-20080206182-A1 | Conjugates of a Polymer and a Protein Linked by an Oxime Group | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2008-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080206182-A1 | Conjugates of a Polymer and a Protein Linked by an Oxime Group | LPO, DAO, DNPEP | TSHR 2741/4885ADRA2A 4419/4885ADRA1A 4233/4885 |
| US-20230242808-A1 | PHOTOCHROMIC COMPOUND AND CURABLE COMPOSITION CONTAINING THE PHOTOCHROMIC COMPOUND | RB1, CRY2, CDK16 | TSHR 3842/4885ADRA2A 4778/4885ADRA1A 4852/4885 |
| US-20110190455-A1 | POLYDIALKYLSILOXANE-BRIDGED BI-PHOTOCHROMIC MOLECULES | UACA, DCLRE1A, RAD54L | TSHR 3623/4885ADRA2A 4164/4885ADRA1A 4551/4885 |
| US-20230133211-A1 | PHOTOCHROMIC CYCLIC COMPOUND AND CURABLE COMPOSITION CONTAINING THE PHOTOCHROMIC CYCLIC COMPOUND | CRY1, CCNL2, CCNT1 | TSHR 4134/4885ADRA2A 4840/4885ADRA1A 4789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.